PARP1 and small cell lung carcinoma: In this study we show for the first time that PI3K/mTOR signaling increases following inhibition of PARP in SCLC and that this may be driven through a reduction in liver kinase B1 (LKB1) signaling–changes validated by PARP1 knockdown.